Adastra Pharmaceuticals
Founded Year
2005Stage
Series E - II | AliveTotal Raised
$90.65MLast Raised
$1.4M | 4 yrs agoAbout Adastra Pharmaceuticals
Adastra Pharmaceuticals is a clinical-stage biopharmaceutical company with a primary focus on oncology. The company is dedicated to developing innovative treatments for aggressive forms of cancer. Its primary customer base is within the healthcare industry, specifically those dealing with oncology. Adastra Pharmaceuticals was formerly known as Tragara Pharmaceuticals. It was founded in 2005 and is based in Princeton, New Jersey.
Loading...
Loading...
Adastra Pharmaceuticals Patents
Adastra Pharmaceuticals has filed 4 patents.
The 3 most popular patent topics include:
- experimental cancer drugs
- transcription factors
- acute myeloid leukemia
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/12/2020 | 11/16/2021 | Transcription factors, Brain tumor, Oncology, Radiation therapy, Experimental cancer drugs | Grant |
Application Date | 8/12/2020 |
|---|---|
Grant Date | 11/16/2021 |
Title | |
Related Topics | Transcription factors, Brain tumor, Oncology, Radiation therapy, Experimental cancer drugs |
Status | Grant |
Latest Adastra Pharmaceuticals News
Oct 6, 2021
Cothera to Advance Clinical Development of Oral Kinase Inhibitor with Unique Myc Depletion I want to thank all the physicians and dedicated healthcare providers who have put forward relentless effort on behalf of their patients as the Adastra team transitions zotiraciclib into Cothera.” — Scott Megaffin, Chief Executive Officer, Adastra PRINCETON, NEW JERSEY, USA, October … Continue reading "Cothera Bioscience Acquires Zotiraciclib from Adastra Pharmaceuticals"
Adastra Pharmaceuticals Frequently Asked Questions (FAQ)
When was Adastra Pharmaceuticals founded?
Adastra Pharmaceuticals was founded in 2005.
Where is Adastra Pharmaceuticals's headquarters?
Adastra Pharmaceuticals's headquarters is located at 202 Carnegie Center, Princeton.
What is Adastra Pharmaceuticals's latest funding round?
Adastra Pharmaceuticals's latest funding round is Series E - II.
How much did Adastra Pharmaceuticals raise?
Adastra Pharmaceuticals raised a total of $90.65M.
Who are the investors of Adastra Pharmaceuticals?
Investors of Adastra Pharmaceuticals include Domain Associates, ProQuest Investments, Mitsubishi, Rusnano, Morgenthaler Ventures and 7 more.
Who are Adastra Pharmaceuticals's competitors?
Competitors of Adastra Pharmaceuticals include Reata Pharmaceuticals, Viracta, Vaccinex, Bexion Pharmaceuticals, Solasia Pharma and 7 more.
Loading...
Compare Adastra Pharmaceuticals to Competitors
Aderis Pharmaceuticals, formerly Discovery Therapeutics, develops and commercializes small molecule, receptor-specific therapeutics for the treatment of central nervous system, cardiovascular and renal diseases.
P2D, Inc. is a pharmaceutical company focused on developing new pharmaceuticals for brain disorders
Verva Pharmaceuticals is an exciting, clinical-stage pharmaceutical company focused on the discovery and development of therapies to treat metabolic diseases (formerly Adipogen).
VGXI is a contract manufacturer of plasmid DNA. The company delivers flexibility, experience, reliability, and value to clients’ challenging programs. The company’s cGMP and non-cGMP products have passed rigorous international regulatory reviews.
Kanisa Pharmaceuticals is a pharmaceutical company focused on the acquisition, development and commercialization of therapeutics in the field of oncology.
Diasome Pharmaceuticals develops hepatocyte-directed vesicle technology. Its cell targeting platform illuminates an understanding of diabetes. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short-acting insulin; and HDV-B, an injectable basal long-acting insulin. Diasome Pharmaceuticals was founded in 2004 and is based in Cleveland, Ohio.
Loading...